Escalier Biosciences' Series A Round

Escalier Biosciences raised a round of funding on March 20, 2017. Investors include New Science Ventures.

Escalier Biosciences is developing both topical and oral RORyt inverse agnostics for the treatment of a broad spectrum of psoriasis patients - from the underserved mild-to-moderate patients that would…

Articles about Escalier Biosciences' Series A Round: